Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 45
Filter
1.
Clin Nephrol ; 69(5): 368-72, 2008 May.
Article in English | MEDLINE | ID: mdl-18538100

ABSTRACT

An association between gadolinium-containing contrast and the development of nephrogenic systemic fibrosis (NSF) has been increasingly recognized. For patients receiving hemodialysis (HD) who are exposed to gadolinium, the Federal Drug Administration (FDA) recommends HD to remove this contrast agent in order to minimize the risk of NSF. This study examines if gadolinium can be removed by frequent exchanges by peritoneal dialysis (PD). Following administration of 0.1 mmol/kg of gadodiamide to a patient with end-stage renal disease, the serum clearance of this contrast agent by automated PD was examined. 10 and 15 exchanges of PD using an automated cycler were respectively performed during the first and second 24-hour periods after gadolinium exposure. Serum gadolinium levels were measured 1 hour after the gadolinium administration, then at 24 and 48 hours after PD was initiated. 90% of the gadolinium was removed from the circulation in 2 days with a regimen of 10-15 exchanges per day of PD. For patients on chronic maintenance PD who receive gadolinium, our case suggests that a temporary intensive automated PD regimen, aimed at maximizing clearance of this contrast agent immediately after exposure, could be an effective alternative when institution of HD is problematic.


Subject(s)
Contrast Media/pharmacokinetics , Gadolinium/pharmacokinetics , Kidney Failure, Chronic/metabolism , Peritoneal Dialysis , Contrast Media/adverse effects , Fibrosis , Gadolinium/adverse effects , Gadolinium DTPA/adverse effects , Gadolinium DTPA/pharmacokinetics , Humans , Kidney Failure, Chronic/complications , Lymphoma/complications , Lymphoma/diagnosis , Lymphoma/drug therapy , Magnetic Resonance Imaging , Male , Middle Aged , Skin Diseases/chemically induced , Skin Diseases/prevention & control
2.
J Immunol ; 167(12): 6841-8, 2001 Dec 15.
Article in English | MEDLINE | ID: mdl-11739501

ABSTRACT

The glycosyltransferase core 2 beta1-6 N-acetylglucosaminyl transferase (C2GnT1 or C2GlcNAcT1) is responsible for formation of branched structures on O-glycans present on cell surface glycoproteins. The O-glycan branch created by C2GnT1 is physiologically important insofar as only this structure can be extended and modified to yield P-selectin ligands that promote initial interactions between extravasating lymphocytes and endothelia. In mature T cells, C2GnT1 activity is thought to be induced as an intrinsic consequence of T cell activation. Through analysis of C2GnT1-dependent epitopes on CD43 and CD45RB we have found that in activated CD8(+) T cells expression of C2GnT1 was dependent upon exposure to specific cytokines rather than being induced as a direct consequence of activation. Activated CD8(+) cells became receptive to strong induction of C2GnT1 expression and P-selectin ligand expression in response to IL-2, moderate induction by IL-15, and minimal induction in response to IL-4. Our observations clarify the relationship between T cell activation and C2GnT1 expression, demonstrate the differential impact of distinct cytokines on expression of C2GnT1 activity and P-selectin ligand, and reinforce the concept that the cytokine milieu subsequent to activation can influence adhesion systems that dictate lymphocyte homing properties.


Subject(s)
Antigens, CD , CD8-Positive T-Lymphocytes/immunology , Interleukin-15/pharmacology , Interleukin-2/pharmacology , Interleukin-4/pharmacology , N-Acetylglucosaminyltransferases/biosynthesis , P-Selectin/metabolism , Animals , CD8-Positive T-Lymphocytes/cytology , CD8-Positive T-Lymphocytes/enzymology , Cell Adhesion , Cells, Cultured , Leukocyte Common Antigens/metabolism , Leukosialin , Ligands , Lymphocyte Activation , Membrane Glycoproteins/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , N-Acetylglucosaminyltransferases/genetics , Polysaccharides/metabolism , RNA, Messenger/biosynthesis , Sialoglycoproteins/genetics , Sialoglycoproteins/metabolism
6.
J Immunol ; 166(1): 256-61, 2001 Jan 01.
Article in English | MEDLINE | ID: mdl-11123300

ABSTRACT

Genetic elimination of CD43 has been associated with increased T cell adhesiveness and T cell hyperresponsiveness to mitogens and alloantigens. Therefore, we investigated whether T cell development was perturbed in CD43-deficient mice by breeding CD43(null) mice with male Ag (Hy)-specific TCR-transgenic mice. Neither positive nor negative thymic selection of male Ag-specific T cells were affected by CD43 status. Furthermore, we did not observe a substantial or consistent hyperresponsive pattern in HY-CD43(null) lymph node cells compared with littermate HY-CD43(+/-) lymph node cells upon analysis of in vitro T cell stimulation with male Ag or mitogen. These observations challenged original conclusions associating absence of CD43 with T cell hyperresponsiveness and led us to re-examine this association. Reported phenotypes of CD43(null) mice have been based on mice with a mixed 129xC57BL/6 genetic background. To exclude a possible influence of genetic background differences among individual mice we analyzed CD43(null) littermates that had been back-bred onto the C57BL/6 background for seven to eight generations. We found that CD43(+) and CD43(null) littermates with the C57BL/6 background exhibited no differences in response to mitogen or alloantigen, thereby establishing that T cell hyperresponsiveness is not a general correlate of CD43 absence.


Subject(s)
Antigens, CD/genetics , Lymphocyte Activation/genetics , Sialoglycoproteins/deficiency , Sialoglycoproteins/genetics , T-Lymphocytes/cytology , T-Lymphocytes/immunology , Animals , Antigens, CD/biosynthesis , Cell Differentiation/genetics , Cell Differentiation/immunology , Cells, Cultured , Crosses, Genetic , Female , H-Y Antigen/biosynthesis , H-Y Antigen/genetics , Leukosialin , Male , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Knockout , Mice, Transgenic , Phenotype , Receptors, Antigen, T-Cell/biosynthesis , Receptors, Antigen, T-Cell/genetics , Sex Factors , T-Lymphocytes/metabolism , Thymus Gland/cytology , Thymus Gland/immunology , Thymus Gland/metabolism
9.
Biochemistry ; 38(38): 12258-65, 1999 Sep 21.
Article in English | MEDLINE | ID: mdl-10493793

ABSTRACT

Cytidine deaminase from E. coli is a dimer of identical subunits (M(r) = 31 540), each containing a single zinc atom. Cytidine deaminase from B. subtilis is a tetramer of identical subunits (M(r) = 14 800). After purification from an overexpressing strain, the enzyme from B. subtilis is found to contain a single atom of zinc per enzyme subunit by flame atomic absorption spectroscopy. Fluorescence titration indicates that each of the four subunits contains a binding site for the transition state analogue inhibitor 5-fluoro-3,4-dihydrouridine. A region of amino acid sequence homology, containing residues that are involved in zinc coordination in the enzyme from E. coli, strongly suggests that in the enzyme from B. subtilis, zinc is coordinated by the thiolate side chains of three cysteine residues (Cys-53, Cys-86, and Cys-89) [Song, B. H., and Neuhard, J. (1989) Mol. Gen. Genet. 216, 462-468]. This pattern of zinc coordination appears to be novel for a hydrolytic enzyme, and might be expected to reduce the reactivity of the active site substantially compared with that of the enzyme from E. coli (His-102, Cys-129, and Cys-132). Instead, the B. subtilis and E. coli enzymes are found to be similar in their activities, and also in their relative binding affinities for a series of structurally related inhibitors with binding affinities that span a range of 6 orders of magnitude. In addition, the apparent pK(a) value of the active site is shifted upward by less than 1 unit. Sequence alignments, together with model building, suggest one possible mechanism of compensation.


Subject(s)
Bacillus subtilis/enzymology , Cytidine Deaminase/chemistry , Cytidine Deaminase/metabolism , Escherichia coli/enzymology , Zinc/chemistry , Zinc/metabolism , Amino Acid Sequence , Binding Sites , Cysteine/chemistry , Cytidine Deaminase/antagonists & inhibitors , Enzyme Inhibitors/chemistry , Hydrogen-Ion Concentration , Kinetics , Models, Molecular , Molecular Sequence Data , Protein Conformation , Pyrimidine Nucleosides/metabolism
10.
J Immunol ; 163(3): 1441-8, 1999 Aug 01.
Article in English | MEDLINE | ID: mdl-10415045

ABSTRACT

The mAb 1B11 has been characterized as recognizing the activation-associated glycoform of murine CD43, a heavily O-glycosylated protein implicated in leukocyte homing. When hemopoietic cells from CD43-/- mice were stained with 1B11, CD43-independent binding of 1B11 was observed on peripheral CD8 T cells and at low levels on thymocytes, while no binding was detected on CD4 T cells, B cells, or bone marrow cells. Levels of 1B11 staining were comparable in lymph node CD8+ T cells from both CD43-/- mice and CD43+/+ mice. We sought to identify the CD43-independent target of 1B11 expressed on CD8 T cells. Previous work had demonstrated that neuraminidase treatment of lymph node cells (LNC) enhanced 1B11 binding on CD43+/+ LNC; this enhancement was also observed in CD43-/- LNC. We show that neuraminidase-enhanced 1B11 binding in CD43-/- LNC and EL4 thymoma cells is CD43 independent and that 1B11 detects a novel target of apparent mass of approximately 200 kDa identified as a hyposialylated form of CD45RB preferentially expressed on peripheral CD8, but not CD4, T cells. Our data also show that the recognition of CD43 and CD45RB by 1B11 is differentially affected by O-linked glycosylation and sialic acid. Whereas 1B11 recognition of CD43 on activated T cells required both core 2 O-glycan branching and sialic acid, 1B11 recognition of CD45 only occurred in the absence of both core 2 glycosylation and sialic acid.


Subject(s)
Antigens, CD , CD8-Positive T-Lymphocytes/immunology , Epitopes, T-Lymphocyte/metabolism , Leukocyte Common Antigens/metabolism , Sialoglycoproteins/metabolism , Animals , Antibodies, Monoclonal/metabolism , Binding Sites, Antibody , CD8-Positive T-Lymphocytes/metabolism , Epitopes, T-Lymphocyte/biosynthesis , Epitopes, T-Lymphocyte/immunology , Exons/immunology , Glycosylation , Leukocyte Common Antigens/biosynthesis , Leukocyte Common Antigens/genetics , Leukocyte Common Antigens/immunology , Leukosialin , Lymph Nodes/cytology , Lymph Nodes/immunology , Lymph Nodes/metabolism , Mice , Mice, Inbred BALB C , Molecular Weight , N-Acetylglucosaminyltransferases/deficiency , N-Acetylglucosaminyltransferases/genetics , N-Acetylglucosaminyltransferases/metabolism , N-Acetylneuraminic Acid/metabolism , Neuraminidase/metabolism , Precipitin Tests , Protein Isoforms/biosynthesis , Protein Isoforms/genetics , Protein Isoforms/immunology , Protein Isoforms/metabolism , Sialoglycoproteins/immunology , Thymoma/immunology , Thymoma/metabolism , Tumor Cells, Cultured
11.
J Immunol ; 161(5): 2348-55, 1998 Sep 01.
Article in English | MEDLINE | ID: mdl-9725230

ABSTRACT

The GTPase superfamily includes a diversity of molecules whose functions are regulated through the binding and hydrolysis of GTP. This superfamily can be segregated into families of functionally related molecules that typically share amino acid sequence similarity within and around the nucleotide-binding domains. A new family of putative GTPases, including IRG-47, LRG-47, IGTP, and TGTP/Mg21, has recently emerged that share significant sequence identity (25-40%). Expression of these molecules has been shown to be selectively induced by IFN-gamma and in some cases by IFN-alpha beta or bacterial LPS. This induction pattern implicates these putative GTPases as part of the innate defense of cells to infection, but their role in such defense has not yet been defined. We have previously described the cloning of TGTP and now confirm its intrinsic activity as a GTPase. We found that TGTP is strongly induced by endogenous IFN-alpha beta produced in response to standard lipofection of plasmid DNA or polyinosinic polycytidylic acid. The ability of endogenously produced IFN-alpha beta to efficiently induce expression of TGTP under these conditions suggested that TGTP might participate in defense against viral infection. This proposal was borne out when TGTP-transfected L cells displayed relative resistance to plaque formation by vesicular stomatitis virus but not herpes simplex virus. This observation places TGTP among a small family of innate antiviral agents and has implications for the functions of other members of this family of GTPases.


Subject(s)
Antiviral Agents/pharmacology , GTP Phosphohydrolases/biosynthesis , GTP-Binding Proteins/physiology , Interferons/pharmacology , Monomeric GTP-Binding Proteins , Animals , DNA, Complementary/genetics , Enzyme Induction/drug effects , Enzyme Induction/immunology , GTP Phosphohydrolases/genetics , GTP Phosphohydrolases/metabolism , GTP-Binding Proteins/biosynthesis , GTP-Binding Proteins/genetics , Interferon-alpha/pharmacology , Interferon-gamma/pharmacology , L Cells , Mice , Receptors, Antigen, T-Cell/physiology , Recombinant Fusion Proteins/metabolism , SAM Domain and HD Domain-Containing Protein 1 , Simplexvirus/drug effects , Simplexvirus/growth & development , Transfection/immunology , Vesicular stomatitis Indiana virus/drug effects , Vesicular stomatitis Indiana virus/growth & development , Viral Plaque Assay
12.
Biochemistry ; 37(34): 11873-8, 1998 Aug 25.
Article in English | MEDLINE | ID: mdl-9718310

ABSTRACT

The binding properties of substrates and competitive inhibitors of Escherichia coli cytidine deaminase are compared with those of the fragments obtained by cutting these ligands at several positions including the glycosidic bond. In contrast with the normal substrate cytidine (kcat/Km = 2.6 x 10(6) M-1 s-1), cytosine is found to serve as an extremely slow substrate (kcat/Km = 1.8 x 10(-3) M-1 s-1), despite the ability of cytosine to enter any active site that can accommodate the normal substrate cytidine. Spontaneous nonenzymatic deamination proceeds at similar rates for cytosine and cytidine at pH 7 and 25 degrees C, indicating that substituent ribose exerts little effect on the intrinsic reactivity of cytidine in solution. Dividing knon by kcat/Km, the maximal Kd value of the enzyme's complex with the altered substrate in the transition state is estimated as 6.1 x 10(-8) M for cytosine, very much higher than the value (1.2 x 10(-16) M) estimated for cytidine. The Kd value of ribofuranose, the missing substituent, is roughly 1.8 x 10(-2) M, as indicated by the Ki values of D-ribose and 1-methyl-D-ribofuranoside as competitive inhibitors. Thus, the free energy of binding of the altered substrate in the transition state is 9.5 kcal/mol more favorable for the whole molecule cytidine than for the sum of those of its parts, cytosine plus ribofuranose. As a separate molecule, however, ribose shows no detectable effect on the enzyme's activity on cytosine. Connectivity effects of similar magnitude are indicated by the equilibrium binding affinities of inhibitors. Thus, the Ki value of the transition state analogue inhibitor zebularine hydrate (1.2 x 10(-12) M) is very much lower than the combined affinities of N-ribofuranosylurea (1.6 x 10(-4) M) and allyl alcohol (0.14 M), indicating that the glycoside bond, by its presence, exerts a connectivity effect of 9.9 kcal/mol on the observed free energy of binding.


Subject(s)
Cytidine Deaminase/chemistry , Cytidine Deaminase/metabolism , Binding Sites , Cytidine/metabolism , Cytidine Deaminase/antagonists & inhibitors , Drug Synergism , Enzyme Inhibitors/metabolism , Escherichia coli/enzymology , Hydroxides/metabolism , Kinetics , Ligands , Models, Chemical , Pyrimidine Nucleosides/metabolism , Substrate Specificity
13.
Biochemistry ; 37(5): 1199-203, 1998 Feb 03.
Article in English | MEDLINE | ID: mdl-9477944

ABSTRACT

The crystal structure of the complex formed between Escherichia coli cytidine deaminase and the transition-state analogue inhibitor 3,4-dihydrouridine [Betts, L., Xiang, S., Short, S. A., Wolfenden, R., & Carter, C. W. (1994) J. Mol. Biol. 235, 635] shows the presence of an H-bond between Glu-91 and the 3'-OH group of substituent ribose, a part of the substrate that is not directly involved in its chemical transformation. To test the contribution of this interaction to transition-state stabilization, Glu-91 was converted to alanine. The mutant enzyme is very much less active than the wild-type enzyme, with a 500-fold increase in Km and a 32-fold reduction in kcat using cytidine as substrate. No change in secondary structure is evident in the circular dichroic spectrum. As measured by kcat/Km, Glu-91 thus appears to stabilize the transition state for cytidine deamination by an overall factor of 1.7 x 10(4), equivalent to -5.8 kcal/mol in free energy. To test the contribution of this interaction in the opposite sense, the 3'-OH group of the substrate was replaced by a hydrogen atom. Comparing 3'-deoxycytidine with cytidine, the native enzyme shows a 17-fold increase in Km and a 400-fold decrease in kcat, indicating that the 3'-hydroxyl group of cytidine stabilizes the transition state for deamination by an overall factor of 6.3 x 10(3), equivalent to -5.2 kcal/mol in free energy, as measured by kcat/Km. After one binding partner has been removed, however, the effect of removing the remaining partner is relatively slight. For the mutant enzyme E91A, removal of the 3'-hydroxyl group from substrate cytidine reduces kcat/Km by a factor of only 3. Complete removal of substituent ribose reduces the wild-type enzyme's kcat/Km by a factor of more than 10(8); thus, substituent ribose, although distant from the site of chemical transformation of the substrate, contributes at least 11 kcal to the free energy of stabilization of the transition state for cytidine deamination, matching the apparent contribution to transition state binding made by the 4-OH group of the pyrimidine ring, which is at the site of substrate transformation [Frick, L., Yang, C., Marquez, V. E., & Wolfenden, R. (1989) Biochemistry 28, 9423].


Subject(s)
Cytidine Deaminase/metabolism , Ribose/metabolism , Amino Acid Substitution/genetics , Cytidine Deaminase/chemistry , Cytidine Deaminase/genetics , Cytosine/metabolism , Deamination , Deoxycytidine/metabolism , Enzyme Stability , Glutamic Acid/genetics , Hydrogen Bonding , Mutagenesis, Site-Directed , Substrate Specificity
14.
J Immunol ; 156(6): 2045-53, 1996 Mar 15.
Article in English | MEDLINE | ID: mdl-8690891

ABSTRACT

In this study, we determined the functional and biochemical differences in naive and primed CD4 T cells that expressed a TCR specific for the pigeon cytochrome c (pcc) peptide presented by I-Ek MHC class II molecules. Naive CD4 T cells expressing the transgenic TCR were isolated from the peripheral lymphoid organs of transgenic mice and stimulated with pcc peptide and IL-2 for 10 to 14 days. After this culture period, the Ag-primed cells were quiescent, as judged by the lack of expression of the early activation marker CD69, low expression of CD25 (IL-2R), and failure to incorporate thymidine. The primed cells required 10-fold less peptide than naive cells to achieve the same degree of proliferation and for the induction of CD69. Primed cells also mobilized calcium more efficiently with regard to Ag dose and magnitude of the response. The biochemical signal-transduction events in naive and primed T cells were compared by stimulating them with different concentrations of pcc peptide presented by adherent Ek-transfected fibroblasts. It was found that tyrosine phosphorylation and activation of mitogen-activated protein kinase (MAPK) in primed cells required 10-fold less Ag and occurred more rapidly and intensively. Interestingly, peptide stimulation induced tyrosine phosphorylation of phospholipase C (PLC)-gamma 1 exclusively in primed cells. RasGAP was also more efficiently tyrosine phosphorylated in primed cells. By contrast, Shc was tyrosine phosphorylated to the same extent in naive and primed cells. PI3Kp85 was not tyrosine-phosphorylated in naive and primed cells either before or after peptide stimulation. We propose that the higher sensitivity of the primed cells to Ag stimulation is most likely dependent, at last in part, on the more efficient activation of PLC-gamma 1, MAPK, and calcium-dependent pathways.


Subject(s)
CD4-Positive T-Lymphocytes/enzymology , Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Cytochrome c Group/immunology , Isoenzymes/metabolism , Peptide Fragments/immunology , Protein-Tyrosine Kinases/metabolism , Type C Phospholipases/metabolism , Animals , CD4-Positive T-Lymphocytes/immunology , Calcium/metabolism , Columbidae , Enzyme Activation/immunology , Epitopes/immunology , Immunophenotyping , Major Histocompatibility Complex/immunology , Mice , Mice, Inbred C57BL , Mitogen-Activated Protein Kinase 1 , Phospholipase C gamma
15.
Biochemistry ; 35(3): 948-54, 1996 Jan 23.
Article in English | MEDLINE | ID: mdl-8547277

ABSTRACT

The 19F-NMR resonance of 5-[19F]fluoropyrimidin-2-one ribonucleoside moves upfield when it is bound by wild-type cytidine deaminase from Escherichia coli, in agreement with UV and X-ray spectroscopic indications that this inhibitor is bound as the rate 3,4-hydrated species 5-fluoro-3,4-dihydrouridine, a transition state analogue inhibitor resembling an intermediate in direct water attack on 5-fluorocytidine. Comparison of pKa values of model compounds indicates that the equilibrium constant for 3,4-hydration of this inhibitor in free solution is 3.5 x 10(-4) M, so that the corrected dissociation constant of 5-fluoro-3,4-dihydrouridine from the wild-type enzyme is 3.9 x 10(-11) M. Very different behavior is observed for a mutant enzyme in which alanine replaces Glu-104 at the active site, and kcat has been reduced by a factor of 10(8). 5-[19F]Fluoropyrimidin-2-one ribonucleoside is strongly fluorescent, making it possible to observe that the mutant enzyme binds this inhibitor even more tightly (Kd = 4.4 x 10(-8) M) than does the native enzyme (Kd = 1.1 x 10(-7) M). 19F-NMR indicates, however, that the E104A mutant enzyme binds the inhibitor without modification, in a form that resembles the substrate in the ground state. These results are consistent with a major role for Glu-104, not only in stabilizing the ES++ complex in the transition state, but also in destabilizing the ES complex in the ground state.


Subject(s)
Cytidine Deaminase/antagonists & inhibitors , Enzyme Inhibitors/metabolism , Binding Sites , Cytidine Deaminase/chemistry , Cytidine Deaminase/metabolism , Fluorescence , Glutamic Acid , Magnetic Resonance Spectroscopy , Spectrophotometry, Ultraviolet
16.
Biochemistry ; 34(13): 4220-4, 1995 Apr 04.
Article in English | MEDLINE | ID: mdl-7703234

ABSTRACT

The crystal structure of an inhibitory complex formed between Escherichia coli cytidine deaminase and the transition-state analog 3,4-dihydrouridine indicates the presence of a short H-bond between Glu-104 and the inhibitor. To test the possibility that analogous H-bonds might play a significant role in stabilizing the hydrated substrate in the transition state for deamination, we replaced Glu-104 by alanine. Compared with the wild-type enzyme, the mutant enzyme's affinities for substrate cytidine and product uridine were found to have increased, whereas kcat for deamination of cytidine had been reduced by 8 orders of magnitude. By its presence, the carboxymethyl group of Glu-104 appears to minimize the activation barrier for deamination, not only by stabilizing the altered substrate in the transition state but also by destabilizing the enzyme-substrate and enzyme-product complexes. In the presence of added formate ion, but not in the presence of bulkier carboxylic acids, the low catalytic activity of the mutant enzyme was enhanced substantially.


Subject(s)
Cytidine Deaminase/chemistry , Alanine , Cytidine/metabolism , Cytidine Deaminase/genetics , Cytidine Deaminase/metabolism , Enzyme Activation/drug effects , Enzyme Stability , Escherichia coli/enzymology , Escherichia coli/genetics , Formates/pharmacology , Glutamic Acid , Hydrogen Bonding , Hydrogen-Ion Concentration , Mutagenesis, Site-Directed , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism , Structure-Activity Relationship , Substrate Specificity , Uridine/metabolism
17.
J Immunol ; 154(4): 1724-34, 1995 Feb 15.
Article in English | MEDLINE | ID: mdl-7836757

ABSTRACT

In this study, we describe a novel full length cDNA clone designated Tgtp that encodes a predicted 415-amino acid a T cell-specific guanine nucleotide triphosphate-binding protein (TGTP) bearing the characteristic motifs of a guanine nucleotide triphosphate (GTP) binding protein. Tgtp is expressed preferentially, if not exclusively, in T cells, and is up-regulated in both unfractionated and in purified CD4+8+ thymocytes upon TCR cross-linking. In contrast, expression of Tgtp is peripheral T cells is maintained at relatively high levels and is not grossly affected by TCR cross-linking. Antiserum generated against synthetic peptides from the predicted TGTP amino acid sequence recognized a single protein with a molecular mass of approximately 50 kDa, corresponding well with the computed molecular mass of 47 kDa. The only known relative of Tgtp is MUSGTP, which is reportedly expressed in B cells and bears a GTP binding motif. Thus, the discovery of Tgtp resolves a subfamily of molecules with GTP binding motifs and apparent lymphoid lineage-restricted expression. Given the restricted expression pattern in T cells, the up-regulated expression observed in response to TCR signaling in immature thymocytes, and the presence of the motifs characteristic of GTP binding proteins, we suggest that TGTP may have an important function in T cell development and/or T cell activation.


Subject(s)
GTP-Binding Proteins/genetics , Genes , Guanosine Triphosphate/metabolism , Monomeric GTP-Binding Proteins , T-Lymphocyte Subsets/metabolism , Amino Acid Sequence , Animals , Base Sequence , Cloning, Molecular , DNA, Complementary/genetics , GTP-Binding Proteins/biosynthesis , Gene Expression Regulation , Male , Mice , Mice, Inbred C57BL , Mice, Inbred DBA , Mice, Transgenic , Molecular Sequence Data , Sequence Alignment , Sequence Homology, Amino Acid , Tumor Cells, Cultured
18.
Biochemistry ; 33(21): 6468-74, 1994 May 31.
Article in English | MEDLINE | ID: mdl-8204580

ABSTRACT

Cytidine deaminase from Escherichia coli contains 1 mol of tightly bound zinc per enzyme subunit (Yang, C., Carlow, D., Wolfenden, R., & Short, S.A. (1992) Biochemistry 31, 4168-4174). When the metal liganding residues Cys-129 and Cys-132 were replaced by Ala, and His-102 was replaced by Ala, Asn, or Gln, deaminase activities of cell extracts containing these mutant enzymes were decreased by several orders of magnitude relative to that of the wild-type enzyme. After purification, each mutant protein was found to contain less than 0.2 mol of zinc per enzyme subunit, except mutant H102Q, which contained 1 mol of zinc per subunit. The activity of each mutant enzyme increased in the presence of added zinc but never attained wild-type activity. Mutant H102N was unique in that this protein could be purified as a stable apoenzyme, activated by added zinc, and then inhibited by EDTA. This mutant enzyme bound zinc with an apparent Kd value of 6.0 x 10(-10) M and regained maximal activity in the presence of 1 mol of zinc per subunit. Affinities of the mutant cytidine deaminases for the transition-state analogue, 5-fluoropyrimidin-2-one ribonucleoside (3,4) hydrate, were found to decrease in rough proportion to kcat/Km over a range spanning several orders of magnitude. This variation in catalytic efficiency arose mainly from effects on kcat, indicating the involvement of zinc coordination in the catalytic process rather than in substrate binding.


Subject(s)
Cytidine Deaminase/chemistry , Zinc/chemistry , Binding Sites , Catalysis , Cytidine Deaminase/genetics , Cytidine Deaminase/isolation & purification , Electrophoresis, Polyacrylamide Gel , Escherichia coli/enzymology , Mutation
19.
Healthc Manage Forum ; 6(1): 4-18, 1993.
Article in English, French | MEDLINE | ID: mdl-10124661

ABSTRACT

In the light of fundamental changes in the delivery of health and social services in Canada, hospital governance must be concerned with protection and enhancement of the organization on behalf of the owner (i.e., taxpayer) as well as accountability to the community it was established to serve. Based on a review of current literature, the authors suggest that the roles and responsibilities of a hospital board entail seven major activities: establish the mission, philosophy and future directions of the institution; choose and evaluate the chief executive officer; establish the ethical principles for the organization; ensure high quality care and services; attract resources to the institution and ensure their effective use; integrate the organization with its environment; and undertake its own self-evaluation, education and development. To play these roles effectively, hospital boards will need to develop more direct links with their communities and learn to share decision making with them.


Subject(s)
Governing Board/organization & administration , Hospitals, Voluntary/organization & administration , Social Responsibility , Canada , Chief Executive Officers, Hospital , Community-Institutional Relations , Ethics, Institutional , Organizational Objectives , Quality Assurance, Health Care/organization & administration , Role , Self-Evaluation Programs
20.
J Immunol ; 148(10): 2988-95, 1992 May 15.
Article in English | MEDLINE | ID: mdl-1578126

ABSTRACT

The maturation of CD4+8- and CD4-8+ thymocytes from CD4+8+ thymocytes is dependent on the mandatory interaction of their alpha beta TCR with selecting ligands expressed on thymic epithelial cells (TE). This is referred to as positive selection. The deletion of CD4+8+ thymocytes that express autospecific TCR (negative selection) is mediated primarily by bone marrow-derived cells. Previous studies have shown that TE is relatively ineffective in mediating the deletion of CD4+8- thymocytes expressing autospecific TCR but TE can render them anergic, i.e., nonresponsive, to the self Ag. The mechanism by which anergy is induced in these cells is unknown. In this study, we used thymocytes expressing a transgenic TCR specific for the male Ag presented by H-2Db class I MHC molecules to examine how expression of the deleting ligand by TE affects thymocyte development and phenotype. The development of female TCR-transgenic thymocytes was examined in irradiated male hosts or in female hosts that had received male fetal thymic epithelial implants. It was observed that the development of transgenic-TCR+ thymocytes was affected in mice with male TE. CD4+8+ thymocytes with reduced CD8 expression and markedly enhanced transgenic TCR expression accumulated in mice with male TE. Development of CD4-8+ thymocytes was also affected in these mice in that fewer were present and they expressed an intermediate CD8 coreceptor level. These CD4-8+ thymocytes expressed a high level of the transgenic TCR, retained the ability to respond to anti-TCR antibodies, but were nonresponsive to male APC. However, the maturation of CD4+8- thymocytes, which are also derived from CD4+8+ precursor cells, was relatively unaffected. In an in vitro assay for assessing negative selection, male TE failed to delete CD4+8+ thymocytes expressing the transgenic TCR under conditions where they were efficiently deleted by male dendritic cells. Collectively these results support the conclusion that male TE was inefficient in mediating deletion. Furthermore, expression of the deleting ligand on thymic epithelium interferes with the maturation of functional male-specific T cells and results in the accumulation of CD4+8+ and CD4-8+ thymocytes expressing a lower level of the CD8 coreceptor but a high level of the transgenic TCR.


Subject(s)
T-Lymphocytes/physiology , Thymus Gland/physiology , Animals , Antigen-Presenting Cells/physiology , CD4 Antigens/analysis , CD8 Antigens/analysis , Cells, Cultured , Epithelium/physiology , Female , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Radiation Chimera , Radiation Tolerance , Receptors, Antigen, T-Cell/analysis , Receptors, Antigen, T-Cell/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...